The majority of British diabetics are being “let down” by their GPs because they are having to wait nearly four years for further much needed treatments.

    Sufferers of type 2 diabetes have to control their blood glucose levels but when this fails they need insulin to keep levels stable.

    But it is a progressive diseases and more intensive treatments are needed to keep the diabetes in check.

    Yet only a third of those needing further medication were actually given it, the University of Leicester study found .

    And “clinical inertia,” the failure to intensify treatment regimens when required, was to blame.

    This means the average waiting time for increased treatment from the start of insulin is 3.7 years and those waiting longest were the elderly or those diagnosed for a long time.

    Researchers warned delays could lead to complications as untreated diabetes can lead to blindness, kidney failure and limb amputations.

    Diabetics are also five times more likely to have cardiovascular disease such as a stroke.

    Type 2 diabetes is often associated with obesity and tends to be diagnosed in older people and numbers are rapidly increasing.

    An estimated one in 16 people Britons or 3.9 million, has diabetes either diagnosed or undiagnosed – nine in ten with type 2.

    It can be prevented from developing by making lifestyle changes such as eating a healthy, balanced diet, losing and maintaining a healthy weight, quitting smoking, cutting down on drinking and exercising.

    As type 2 diabetes usually gets worse, diabetics may eventually need medication to keep blood glucose at normal levels.

    Yet maintaining tight control of blood sugars in Type 2 diabetes can lead to significant reductions in related complications

    Professor Kamlesh Khunti said: “Type 2 diabetes is a progressive disease characterised by a decline in ?-cell function and loss of glycaemic control, with many patients ultimately requiring intensification of their treatment regimen.

    “Guidelines for the treatment of patients with type 2 diabetes suggest that tight glycaemic control should be maintained – defined as glycated haemoglobin (HbA1c) less than 7.0% (53 mmol/mol) – through active titration of combinations of antihyperglycaemic medications and lifestyle modification, as appropriate.

    “Additional antihyperglycaemic drugs may be added if the HbA1c level continues to remain above the recommended target of 7.0%.

    “If HbA1c is greater than 7.5% (58 mmol/mol), further intensification, including the use of insulin, is recommended.

    “As people with diabetes move through the recommended treatment algorithm, those patients who are suboptimally controlled according to the guideline targets may be at greater risk of long-term diabetes-related complications.

    “Of the 11,000 patients we studied, only a third of those needing further medication were actually given it.

    “Clinical inertia is a global phenomenon, which is putting people with Type 2 diabetes at further risk of preventable complications associated with the condition.”

    The retrospective cohort study investigated whether clinical inertia exists in people with type 2 diabetes treated with basal insulin.

    It involved 11,696 patients with type 2 diabetes in the UK Clinical Practice Research Datalink database between January 2004 and December 2011, with follow-up until December 2013.

    Prof Khunti added: “In conclusion, the present study shows that there is a significant delay in the intensification of treatment in people with type 2 diabetes with poor glycaemic control, and that many patients do not have their treatment intensified at all.

    “Clinical inertia appears to exist at both the initiation and intensification of insulin therapy.

    “This may have a negative impact on the long-term outcomes for patients.

    “More detailed studies, perhaps using patient and physician questionnaires, should attempt to establish the reasons for a delay in intensification, particularly among elderly people with diabetes and those with comorbidities.”

    The study was published in the journal Diabetes, Obesity and Metabolism.


      • After originally starting her journalism career at local paper the Leicester Mercury, Laura moved to Bristol to become a senior reporter at SWNS. She now runs the ‘Sell Us Your Story’ website, gathering different stories and undertaking general reporting and copywriting duties.

        • Show Comments (0)

        Your email address will not be published. Required fields are marked *

        comment *

        • name *

        • email *

        • website *

        This site uses Akismet to reduce spam. Learn how your comment data is processed.


        You May Also Like

        Regeneration at its Finest: A Look at the Old Police Station

        The property market has made an interesting shift in recent times, at least according ...



        This footage shows a man throwing tiles of a roof into posh into car ...

        Pregnant women with whose blood pressure is even slightly raised can be dramatically more at risk of developing diabetes or heart disease, say scientists. In the first study of its kind a condition called pre-hypertension - where blood pressure is in the upper range of normal - has been shown to be potentially dangerous. Up to one-in-seven expectant mothers in the UK already suffer high blood pressure and the discovery could lead to many more requiring monitoring. Professor Jian-Min Niu, of Guangdong Women and Children Hospital in China, said: "Our findings underscore an important issue that has been long ignored in clinical practice - the fact criteria for hypertension in pregnancy are derived from the general population. "We anticipate if reaffirmed in further research, our study could spark a change in what we currently deem healthy blood pressure in pregnant women." The research found pregnant women whose blood pressure is in the upper ranges of normal could be at high risk of developing metabolic syndrome - a combination of diabetes, hypertension and obesity - and heart disease risk after giving birth. Current guidelines do not distinguish between pregnant women and the general population and define hypertension as persistently elevated blood pressure that is 140 millimeters of mercury (mm Hg) systolic or 90 mm Hg diastolic and above. Readings of 120-139 mm Hg systolic over 80-89 mm Hg diastolic is deemed 'pre-hypertension' - a warning sign of high blood pressure in the future. But the study published in Hypertension said pregnant women with blood pressure in this range had 6.5 times greater odds of developing metabolic syndrome compared to those in the lower normal range. It looked at 507 Chinese women with uncomplicated pregnancies, no history of hypertension and normal blood sugar and cholesterol who underwent seven or more blood pressure measurements along with other standard tests including weight measurements and foetal ultrasounds. Blood sugar and cholesterol levels were also tested at the start, shortly before and after giving birth and once every few months for up to 1.6 years after giving birth. The participants were grouped into three categories including those whose blood pressure remained on the lower end of normal (34%), around the mid-point (52%) or in the pre-hypertension range (13%). A series of snapshot measurements did not predict future risk but patterns of repeated elevations did - highlighting the dynamic nature of blood pressure during pregnancy. The results support the idea of pregnancy as a cardiovascular stress test for women that can reveal underlying disturbances in blood pressure regulation, glucose and cholesterol metabolism. Abnormalities in all three areas can disrupt functions and lead to full-blown cardiovascular disease years down the road. Prof Niu said globally the burden of cardio-metabolic diseases in women has been rising steadily over the last decades. He said: "Blood pressure measurements are already done as matter of routine and cost-effective checkups during pregnancy so our findings underscore this tool's potential to gauge a woman's post-partum cardiovascular risk. "Early identification of metabolic risk factors and implementation of lifestyle modifications may help delay the onset of cardiovascular disease that would present itself 20 to 30 years after delivery."


        An NHS mental health worker accused of sexually abusing vulnerable teenage girls has admitted ...